SR 27417

Known as: SR-27417, SR27417A 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-1997
01219921997

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
BACKGROUND & AIMS Platelet-activating factor (PAF) is increased during relapse of ulcerative colitis. In animal models of… (More)
Is this relevant?
1998
1998
The level of calcitonin gene related peptide (CGRP) in plasma and pulmonary lavage fluid was tested by radio-immunoassay on… (More)
Is this relevant?
1997
1997
Platelet-activating factor (PAF) is a lipid-derived mediator that has been implicated in the pathophysiology of airway… (More)
Is this relevant?
1997
1997
SR 27417, a potent PAF receptor antagonist, inhibited in a dose-dependent manner the hypotensive effect of PAF in rats. It… (More)
Is this relevant?
1995
1995
We examined the effect of platelet-activating factor (PAF) on gastric acid secretion by isolated rabbit gastric glands as… (More)
Is this relevant?
1994
1994
Effect of three specific PAF antagonists, SR-27417, BN-50739 and ginkgolide derivative BN-52021 have been evaluated in models of… (More)
Is this relevant?
1993
1993
SR 27417, the first member of a newly developed PAF antagonist series, fully and competitively displaced [3H]PAF from its high… (More)
Is this relevant?
1992
1992
Pharmacodynamics of SR 27417, a novel, specific platelet-activating factor (PAF) antagonist was monitored with ex vivo PAF… (More)
Is this relevant?